NYSE:MRKPharmaceuticals
Is It Time To Reassess Merck (MRK) After Its Strong Multi Year Share Price Run?
If you are wondering whether Merck is still reasonably priced after its run in recent years, this article will walk through what the current share price might be implying about future value.
At a last close of US$119.30, Merck has recorded a 2.1% decline over the past 7 days, alongside returns of 10.5% over 30 days, 12.1% year to date, 36.7% over 1 year, 22.2% over 3 years and 103.2% over 5 years.
Recent attention on large pharmaceutical names and ongoing sector headlines have kept Merck in...